Walking Fish Therapeutics, Inc. — Form D
Walking Fish Therapeutics, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-03. The offering totals $23.4M, of which $12.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-03-03
- Form: D
- Accession: 0001882704-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $23.4M
- Amount sold: $12.7M
- Remaining: $10.7M
- Investors: 3
- Date of first sale: 2022-02-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-435701
Issuer
- Name: Walking Fish Therapeutics, Inc.
- CIK: 0001882704
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 280 UTAH AVENUE, SUITE 250, SOUTH SAN FRANCISCO, CA, 94080
- Phone: (650) 331-0242
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Franklin T Berger | Director | South San Francisco, CA |
| Antonin de T Fougerolles | Director | South San Francisco, CA |
| Daniel T Janse | Director | South San Francisco, CA |
| Alexis T Ji | Director | South San Francisco, CA |
| Manish T Kothari | Director | South San Francisco, CA |
| Lewis T Williams | Director | South San Francisco, CA |
| Momo T Wu | Director | South San Francisco, CA |
| Stella T Xu | Director | South San Francisco, CA |
| Lewis T Williams | Executive Officer | South San Francisco, CA |
| Antonin de M Fougerolles | Director | South San Francisco, CA |
| Stella M Xu | Director | South San Francisco, CA |
| Alexis M Ji | Director | South San Francisco, CA |
| Franklin M Berger | Director | South San Francisco, CA |
| Momo M Wu | Director | San Francisco, CA |
Other filings by this issuer (1)
More